Nuclear Notch3 Expression is Associated with Tumor Recurrence in Patients with Stage II and III Colorectal Cancer

被引：48

作者：

Ozawa, Tsuyoshi ^{[1
]}

Kazama, Shinsuke ^{[1
]}

Akiyoshi, Takashi ^{[2
]}

Murono, Koji ^{[1
]}

Yoneyama, Satomi ^{[1
]}

Tanaka, Toshiaki ^{[1
]}

Tanaka, Junichiro ^{[1
]}

Kiyomatsu, Tomomichi ^{[1
]}

Kawai, Kazushige ^{[1
]}

Nozawa, Hiroaki ^{[1
]}

Kanazawa, Takamitsu ^{[1
]}

Yamaguchi, Hironori ^{[1
]}

Ishihara, Soichiro ^{[1
]}

Sunami, Eiji ^{[1
]}

Kitayama, Joji ^{[1
]}

Morikawa, Teppei ^{[3
]}

Fukayama, Masashi ^{[3
]}

Watanabe, Toshiaki ^{[1
]}

机构：

[1] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan

[2] Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan

[3] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan

来源：

ANNALS OF SURGICAL ONCOLOGY | 2014年 / 21卷 / 08期

关键词：

HUMAN BREAST-CANCER; COLON-CANCER; METASTASIS; SURVIVAL; GROWTH; GENE;

D O I：

10.1245/s10434-014-3659-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The importance of Notch signaling in colorectal cancer (CRC) tumorigenesis has been recently recognized. However, the significance of Notch3 expression and its association with Notch1 expression in CRC is unclear. In the present study, we investigated Notch1 and Notch3 expression in Stage II and III CRC to assess their association with clinicopathological characteristics. The protein expression of Notch1 and Notch3 was examined using immunohistochemistry in 305 CRC specimens. Nuclear expression of Notch1 and Notch3 and their associations with clinicopathological characteristics and distant relapse-free survival (dRFS) were evaluated. Nuclear Notch1 was overexpressed in 37 % of specimen, and nuclear Notch3 in 38 %. Nuclear Notch3 expression correlated with tumor differentiation status (P = 0.0099). Nuclear expression of Notch1 and Notch3 was associated with tumor recurrence (P = 0.0311 and P = 0.0053, respectively). In multivariate analysis, nuclear Notch3 expression [hazard ratio (HR) = 1.71; 95 % confidence interval (CI), 1.06-2.78; P = 0.0271), lymph node metastasis, and venous involvement were independently correlated with dRFS. In subgroup analysis, nuclear Notch3 expression was strongly associated with dRFS in Stage II CRC (HR = 3.47; 95 % CI 1.44-9.22; P = 0.0055). Both nuclear Notch1 and Notch3 were positive in 67 specimens (22 %) and both were negative in 144 specimens (47 %). Coexpression of nuclear Notch1 and Notch3 had an additive effect toward poorer dRFS compared with a negative subtype (HR = 2.48; 95 % CI, 1.41-4.40; P = 0.0019). Nuclear Notch3 expression might be a novel predictive marker for recurrence in Stage II and III CRC.

引用

页码：2650 / 2658

页数：9

共 26 条

[1] NOTCH: THE PAST, THE PRESENT, AND THE FUTURE [J].